Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-20-024588)

Filing Details

Accession Number:: 0001437749-20-024588
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-30 19:49:11
Reporting Period:: 2020-11-24

Accepted Time:: 2020-11-30 19:49:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
834365	Biolife Solutions Inc	BLFS	Electromedical & Electrotherapeutic Apparatus (3845)	943076866

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1273547	Thomas Girschweiler	C/O Biolife Solutions, Inc. 3303 Monte Villa Parkway, Suite 310 Bothell WA 98021		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-11-24	1,600,000	$22.50	47,774	No	4	S	Indirect	By Taurus4757 GmbH

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Taurus4757 GmbH

Footnotes

The reported securities were sold to Casdin Partners Master Fund, L.P. in a private transaction (the "Transaction"). As of November 24, 2020, all material conditions precedent to closing the Transaction have been satisfied.
The shares of common stock, par value $0.001 per share, are held directly by Taurus457 GmbH an entity wholly owned by Thomas Girschweiler, a director of Biolife Solutions, Inc.